J Breast Cancer.  2013 Jun;16(2):193-197. 10.4048/jbc.2013.16.2.193.

Comparison of Outcomes of Standard and Oncoplastic Breast-Conserving Surgery

Affiliations
  • 1Department of General Surgery, Ankara Oncology Training and Education Hospital, Ankara, Turkey. mgulcelik@yahoo.com

Abstract

PURPOSE
The aim of this study is to determine and to compare the oncological outcomes of bilateral reduction mammoplasty to standard breast-conserving surgery for breast cancer.
METHODS
One hundred sixty-two patients who received a quadrantectomy because of breast cancer (group 1) and 106 breast cancer patients with macromastia who underwent breast-conserving surgery via bilateral reduction mammoplasty (group 2) between 2003 and 2010 were enrolled in this study.
RESULTS
The mean follow-up time was 37 months for group 1 and 33 months for group 2. Surgical margins were wider than 2 mm in 82.7% and 10 mm in 76.5% of the patients in group 1. Eleven percent of patients had positive surgical margins in this group. When compared to group 2, the rates were 89%, 84%, and 8.4%, respectively. Three patients (1.8%) in group 1 and one patient (0.9%) in group 2 had local recurrence of the disease and received a mastectomy. No statistical significances were noted for either local recurrence or overall survival between the two groups.
CONCLUSION
Bilateral reduction mammoplasty has some advantages as compared to the standard conventional breast-conserving surgery techniques without having any unfavorable effects on surgical margin confidence, local recurrence, and survival rates.

Keyword

Breast neoplasms; Mammoplasty; Oncoplastic surgery; Segmental mastectomy

MeSH Terms

Breast
Breast Neoplasms
Female
Follow-Up Studies
Humans
Hypertrophy
Mammaplasty
Mastectomy
Mastectomy, Segmental
Recurrence
Survival Rate
Breast
Hypertrophy

Figure

  • Figure 1 The illustration of bilateral reduction mammoplasty technique.

  • Figure 2 Postoperative pictures of bilateral reduction mammoplasty and quadrantectomy groups.

  • Figure 3 Five-year disease-free survival (DFS).


Cited by  1 articles

Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis
Jun-Ying Chen, Yi-Jie Huang, Liu-Lu Zhang, Ci-Qiu Yang, Kun Wang
J Breast Cancer. 2018;21(3):321-329.    doi: 10.4048/jbc.2018.21.e36.


Reference

1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347:1227–1232.
Article
2. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000; 92:1143–1150.
Article
3. Morrow M. Minimally invasive surgery for breast cancer. BMJ. 2009; 338:b557.
Article
4. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001; 12:997–1003.
Article
5. Spear SL, Pelletiere CV, Wolfe AJ, Tsangaris TN, Pennanen MF. Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg. 2003; 111:1102–1109.
Article
6. Clough KB, Lewis JS, Couturaud B, Fitoussi A, Nos C, Falcou MC. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg. 2003; 237:26–34.
Article
7. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347:1233–1241.
Article
8. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366:2087–2106.
Article
9. Fernando IN, Ford HT, Powles TJ, Ashley S, Glees JP, Torr M, et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1996; 8:226–233.
Article
10. Brierley JD, Paterson IC, Lallemand RC, Rostom AY. The influence of breast size on late radiation reaction following excision and radiotherapy for early breast cancer. Clin Oncol (R Coll Radiol). 1991; 3:6–9.
Article
11. Asgeirsson KS, Rasheed T, McCulley SJ, Macmillan RD. Oncological and cosmetic outcomes of oncoplastic breast conserving surgery. Eur J Surg Oncol. 2005; 31:817–823.
Article
12. Kaur N, Petit JY, Rietjens M, Maffini F, Luini A, Gatti G, et al. Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol. 2005; 12:539–545.
Article
13. Giacalone PL, Roger P, Dubon O, El Gareh N, Rihaoui S, Taourel P, et al. Comparative study of the accuracy of breast resection in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol. 2007; 14:605–614.
Article
14. Giacalone PL, Roger P, Dubon O, El Gareh N, Daurés JP, Laffargue F. Lumpectomy vs oncoplastic surgery for breast-conserving therapy of cancer. A prospective study about 99 patients. Ann Chir. 2006; 131:256–261.
15. Clough KB, Kroll SS, Audretsch W. An approach to the repair of partial mastectomy defects. Plast Reconstr Surg. 1999; 104:409–420.
Article
16. Nos C, Fitoussi A, Bourgeois D, Fourquet A, Salmon RJ, Clough KB. Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. Eur J Surg Oncol. 1998; 24:508–514.
Article
17. McCulley SJ, Macmillan RD. Therapeutic mammaplasty-analysis of 50 consecutive cases. Br J Plast Surg. 2005; 58:902–907.
Article
18. Caruso F, Catanuto G, De Meo L, Ferrara M, Gallodoro A, Petrolito E, et al. Outcomes of bilateral mammoplasty for early stage breast cancer. Eur J Surg Oncol. 2008; 34:1143–1147.
Article
19. Fitoussi AD, Berry MG, Famà F, Falcou MC, Curnier A, Couturaud B, et al. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases [outcomes article]. Plast Reconstr Surg. 2010; 125:454–462.
Article
20. Rietjens M, Urban CA, Rey PC, Mazzarol G, Maisonneuve P, Garusi C, et al. Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast. 2007; 16:387–395.
Article
21. Chakravorty A, Shrestha AK, Sanmugalingam N, Rapisarda F, Roche N, Querci Della, et al. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery. Eur J Surg Oncol. 2012; 38:395–398.
Article
22. Down SK, Jha PK, Burger A, Hussien MI. Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer. Breast J. 2013; 19:56–63.
Article
Full Text Links
  • JBC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr